October 2023

MIMS Full Prescribing Update

New / Revised

Product Name

Section changed
New Adefovir Dipivoxil Tablets (SigmaPharm Laboratories)
New Alburex 5 AU
New Ampicillin for Injection, USP (Mylan, USA)
New Bactrim 400/80 Concentrate for Solution for Infusion
New Bendamustine Juno
New Bendarabine (Germany)
New Berocca Energy
New Brufen Pain
New BTC Candesartan HCT
New Cefaclor Sun
New Demazin Nasal Decongestant
New Dexamethasone Medsurge
New Elevit DHA & Choline Pregnancy
New Esmolol Hydrochloride Medsurge
New Fingolimod Sandoz
New Fludarabin Actavis (Teva Sweden)
New Glyconeo
New Mianserin Tablets (Mylan UK)
New Mounjaro
New Neuro Sleep
New Onureg
New Padcev
New Pharmacy Choice Sinus Nasal Decongestant
New Solu-Medrone (Pfizer, UK)
New Ultra Nature Bone Strength & Restore
New Ultra Nature Selancy Men
New Ultra Nature Skin Clear
New Vaxchora
New Verorab
New WP Gabapentin Capsules
New WP Gabapentin Tablets
Reinstated Hydromorphone Hydrochloride Oral Solution 1 mg/mL USP (Hikma)
Revised Aclasta Qualitative and Quantitative Composition, Sponsor
Revised Acular Eye Drops TGA Date
Revised Aczone TGA Date
Revised Adacel Polio Nature and Contents of Container
Revised Aklief Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Shelf Life
Revised AKM Dabigatran Adverse Effects (Undesirable Effects), New contraindication, Special Warnings and Precautions for Use
Revised Albalon Dose and Method of Administration
Revised Albalon-A Dose and Method of Administration
Revised Alcaine Eye Drops 0.5% Adverse Effects (Undesirable Effects)
Revised Amcal Osteo Relief Paracetamol TGA Date
Revised AndroFeme 1 Adverse Effects (Undesirable Effects), List of Excipients
Revised AndroForte 5 List of Excipients
Revised APO-Allopurinol (was Allopurinol APOTEX) List of Excipients, Physicochemical Properties, Product Name change, Qualitative and Quantitative Composition, Sponsor
Revised APO-Clonidine TGA Date
Revised APO-Esomeprazole Sponsor
Revised APO-Fentanyl Boxed Warnings, Overdose, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use
Revised APOHealth Osteo Relief Paracetamol TGA Date
Revised APO-Lansoprazole Sponsor
Revised APO-Memantine Sponsor
Revised Apomine Intermittent Contraindications, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions
Revised Apomine Solution for Infusion Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, New contraindication
Revised APO-Nebivolol Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised APO-Olanzapine (was Olanzapine APOTEX) Product Name change, Qualitative and Quantitative Composition
Revised APO-Perindopril Arginine/Amlodipine TGA Date
Revised APO-Pramipexole TGA Date
Revised APO-Propranolol Sponsor
Revised APO-Rosuvastatin (was Rosuvastatin APOTEX) Product Name change
Revised APO-Simvastatin Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised APO-Topiramate Contraindications, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised APO-Tramadol Adverse Effects (Undesirable Effects), Sponsor
Revised Aprepitant ARX (was Aprepitant APOTEX) Product Name change
Revised APX-Diazepam TGA Date
Revised APX-Quetiapine Product Name change, Qualitative and Quantitative Composition
Revised Arabloc List of Excipients, Pharmaceutical Form, Qualitative and Quantitative Composition
Revised ARX-Letrozole (was Letrozole APOTEX) Product Name change
Revised Ataris TGA Date
Revised Ausfam TGA Date
Revised Belkyra TGA Date
Revised BioActivated B Description, Indications
Revised Bonjela Product Name change
Revised Botox TGA Date
Revised Buvidal Monthly Sponsor
Revised Buvidal Weekly TGA Date
Revised Catapres 100 Pharmaceutical Form
Revised Catapres 150 Tablets and Catapres Ampoules Pharmaceutical Form
Revised C-Caps Description
Revised Cephalex Adverse Effects (Undesirable Effects), Pharmaceutical Form, Special Warnings and Precautions for Use
Revised Cetrotide Nature and Contents of Container
Revised Chemists' Own Sinus + Allergy & Pain Relief TGA Date
Revised Chemists' Own Sinus + Pain Relief Adverse Effects (Undesirable Effects), Contraindications, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Nature and Contents of Container, Pharmacological Properties, Physicochemical Properties, Special Warnings and Precautions for Use
Revised Chemists' Own Sinus and Nasal Decongestant TGA Date
Revised Cipramil Special Warnings and Precautions for Use
Revised Clonac Fertility, Pregnancy and Lactation
Revised Combigan TGA Date
Revised Comirnaty Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Shelf Life, Special Warnings and Precautions for Use
Revised Comirnaty (Tris/Sucrose Presentation) Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Shelf Life, Special Warnings and Precautions for Use
Revised Comirnaty Original/Omicron BA.1 Shelf Life
Revised Comirnaty Original/Omicron BA.4-5 Shelf Life
Revised Contrave 8/90 Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Cosmegen Adverse Effects (Undesirable Effects)
Revised Cyclogyl Adverse Effects (Undesirable Effects)
Revised Dasatinib ARX TGA Date
Revised DBL Cytarabine 1 g/10 mL Injection Fertility, Pregnancy and Lactation, Fertility, Pregnancy and Lactation
Revised DBL Cytarabine 2 g/20 mL Injection Fertility, Pregnancy and Lactation, Fertility, Pregnancy and Lactation
Revised DBL Fluorouracil Injection BP Adverse Effects (Undesirable Effects)
Revised DBL Gentamicin Injection BP Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Difflam PLUS Sore Throat & Mouth Solution Antiseptic + Anti-Inflammatory Ready to Use Product Name change
Revised Difflam Sore Throat & Mouth Solution Anti-Inflammatory Ready to Use Product Name change
Revised Dilart List of Excipients, Nature and Contents of Container
Revised Dolapril TGA Date
Revised Doxylin List of Excipients, Nature and Contents of Container, Physicochemical Properties, Qualitative and Quantitative Composition
Revised Dupixent Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Edurant Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use
Revised E-Mycin TGA Date
Revised Epiduo Forte List of Excipients
Revised Epiramax Contraindications, Fertility, Pregnancy and Lactation, Nature and Contents of Container, Special Warnings and Precautions for Use
Revised Eryc Capsules Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Esbriet Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Esbriet Tablets Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Eumovate Fertility, Pregnancy and Lactation
Revised Evoltra Nature and Contents of Container
Revised Exelon Deleted Presentation
Revised Fenocol Qualitative and Quantitative Composition
Revised Fentanyl Sandoz Overdose, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use
Revised Fibsol Pharmaceutical Form
Revised Flubiclox Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Flumazenil Kabi TGA Date
Revised Fluorouracil Accord Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use
Revised FluQuadri Nature and Contents of Container
Revised FML TGA Date
Revised Forxiga TGA Date
Revised Ganfort 0.3/5 TGA Date
Revised Ganfort PF 0.3/5 TGA Date
Revised Hequinel TGA Date
Revised HistEase Description, Dosage and Administration, Indications, Precautions
Revised Ibrance Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Isoptin Injection Adverse Effects (Undesirable Effects), Dose and Method of Administration, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use
Revised Isturisa Pharmaceutical Form
Revised Kerendia TGA Date
Revised Ketorolac Kabi Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Keytruda Adverse Effects (Undesirable Effects)
Revised Korsuva TGA Date
Revised Lamictal Pharmacological Properties, Special Warnings and Precautions for Use
Revised Lamivudine Viatris Product Name change, Special Precautions for Storage
Revised Lexapro Special Warnings and Precautions for Use
Revised Lorazepam Viatris List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Product Name change, Qualitative and Quantitative Composition
Revised Lumigan TGA Date
Revised Lumigan PF TGA Date
Revised Maviret Dosage and Administration, New Presentation of Brand already available, Therapeutic Indications
Revised Mayne Pharma Erythromycin Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Medsurge Alfentanil Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Mesasal Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Methotrexate Accord Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Metronidazole Kabi Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Minirin Tablets Qualitative and Quantitative Composition
Revised Monofer Adverse Effects (Undesirable Effects)
Revised Neuroccord Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Nexole Sponsor
Revised Nordip Nature and Contents of Container, Qualitative and Quantitative Composition
Revised Noten Pharmaceutical Form
Revised Noumed Telmisartan Pharmaceutical Form
Revised Nubeqa Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use
Revised Nuvaxovid Nature and Contents of Container
Revised Ocuflox TGA Date
Revised Olanzapine NNA (was Pryzex) Product Name change
Revised Olanzapine Sandoz Adverse Effects (Undesirable Effects)
Revised Olanzapine Sandoz ODT Adverse Effects (Undesirable Effects)
Revised Omeprazole Sandoz Capsules Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Omeprazole Sandoz Tablets Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Ondansetron SZ Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Ondansetron Viatris Tablets TGA Date
Revised Opdivo Dose and Method of Administration
Revised Osteovan Qualitative and Quantitative Composition, Sponsor
Revised Otezla Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties
Revised Ozurdex TGA Date
Revised Paclitaxel Accord Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Pfizer (Australia) Cytarabine Injection Fertility, Pregnancy and Lactation
Revised Pfizer (Australia) Gentamicin Injection BP Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Pharmacor Cefuroxime Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Pharmacor Dabigatran Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Phenasen Contraindications, Fertility, Pregnancy and Lactation, Pharmacological Properties
Revised Plaquenil Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Pneumovax 23 Adverse Effects (Undesirable Effects)
Revised Pravachol Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Probitor Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Prolia Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Rozex Cream TGA Date
Revised Rozex Gel Pharmaceutical Form
Revised Sifrol and Sifrol ER Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use
Revised Simvar Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Skyrizi Dose and Method of Administration, Special Precautions for Storage
Revised Sodium Chloride Injection BP 0.9% (Fresenius Kabi) List of Excipients, Nature and Contents of Container
Revised Somatuline Autogel Special Precautions for Storage
Revised Spikevax Bivalent Original/Omicron Adverse Effects (Undesirable Effects), Pharmacological Properties
Revised Spikevax Bivalent Original/Omicron BA.4-5 Therapeutic Indications
Revised Stelax TGA Date
Revised Sublimaze Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use
Revised SynQ10 Description
Revised Taltz Pharmacological Properties
Revised Tamiflu Qualitative and Quantitative Composition
Revised Temaze List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition, Special Precautions for Storage
Revised Tenofovir ARX Product Name change, Sponsor
Revised Tramadol Sandoz SR Adverse Effects (Undesirable Effects)
Revised Tramedo Adverse Effects (Undesirable Effects), Pharmacological Properties
Revised Trodelvy TGA Date
Revised Trust Sinus & Nasal Decongestant Sponsor
Revised Ultra Nature Selancy Women Dose and Method of Administration, Indications, Precautions
Revised Uremide Nature and Contents of Container, Pharmaceutical Form, Special Precautions for Storage
Revised Valpam Qualitative and Quantitative Composition
Revised Vancomycin Viatris Dose and Method of Administration
Revised Veltassa Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions
Revised Voltaren Rapid 12.5 TGA Date
Revised Vumerity Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use
Revised Vyndamax Adverse Effects (Undesirable Effects)
Revised Water For Injections BP (Fresenius Kabi) Nature and Contents of Container
Revised Yuflyma Autoinjector Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Pharmacological Properties, Qualitative and Quantitative Composition
Revised Yuflyma Prefilled Syringe Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Qualitative and Quantitative Composition
Revised Zaldiar Adverse Effects (Undesirable Effects)
Revised Zimstat Adverse Effects (Undesirable Effects), List of Excipients, Nature and Contents of Container, Special Warnings and Precautions for Use
Revised Zinc Chloride Concentrated Injection (Phebra) TGA Date
Revised Zomig Special Precautions for Storage
Revised Zydol Adverse Effects (Undesirable Effects), Overdose
Revised Zydol SR Adverse Effects (Undesirable Effects)
Revised Zypine, Zypine ODT Adverse Effects (Undesirable Effects)
Deleted APO-Fosinopril
Deleted APO-Gliclazide
Deleted Blackmores Reme-D for Migraine-Headache
Deleted Cilamox
Deleted Elevit DHA
Deleted Gold Cross SleepWell
Deleted Hydrocortisone Tablets, USP (Strides)
Deleted Pregnyl Vial
Deleted Ristempa
Deleted Rythmodan
Deleted StemGuard
Deleted Telmisartan HCT GH
Deleted Ubiquinol-Q10 Max
Deleted Wockhardt Heparin Sodium Flushing Solution (UK)

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Suite 1602, Level 16
44 Market Street
Sydney NSW 2000
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au